BioSpace News Archive

Genetown

Axena Health Commends New Study Showing the Leva System’s Long-term Treatment Efficacy for Female Urinary Incontinence

Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, announced today that leading pelvic health researchers have published a new study demonstrating the Leva® Pelvic Health System’s long-term treatment efficacy for female urinary incontinence (UI).

January 23, 2024
·
9 min read
Business

Mercury Bio Joins the Alliance for mRNA Medicines

Mercury Bio today announced that it has joined the Alliance for mRNA Medicines as a charter member, and that Chief Science Officer Richard Sayre, Ph.D. has joined the Alliance for mRNA Medicines (AMM) board.

January 23, 2024
·
2 min read
BioMidwest

Elephas Announces $55 Million in Series C Funding

Elephas Biosciences Corporation (Elephas), a private company, announced today that it has raised $55 million in Series C funding.

January 23, 2024
·
6 min read
Business

Varex Schedules First Quarter Fiscal Year 2024 Earnings Release and Conference Call

Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the first quarter of fiscal year 2024 following the close of regular trading on Tuesday, February 6, 2024.

January 23, 2024
·
1 min read
Cytomos appoints new Chief Commercial and Innovation Officer and Techno-Commercial Adviser: Driving the commercialisation strategy as the company evolves from an R&D to a product-based business

Cytomos (www.cytomotos.com) is pleased to announce the appointment of Dr Fernanda Masri as Chief Commercial and Innovation Officer and Dr Christel Fenge

January 23, 2024
·
6 min read
IDBS announces data management partnership with PharmaEssentia Innovation Research Center

IDBS announced that it has entered into a partnership with Massachusetts-based PharmaEssentia Innovation Research Center on its Polar platform to help digitize data management and facilitate collaboration between the company’s global research and development teams.

January 23, 2024
·
2 min read
Pharm Country

BD Board Declares Dividend - Jan 23, 2024

The Board of Directors of BD announced it has declared a quarterly dividend of $0.95 per common share, payable on March 29, 2024 to holders of record on March 8, 2024.

January 23, 2024
·
1 min read
Business

Exelixis to Release Fourth Quarter and Fiscal Year 2023 Financial Results on Tuesday, February 6, 2024

Exelixis, Inc. (Nasdaq: EXEL) announced today that its fourth quarter and fiscal year 2023 financial results will be released on Tuesday, February 6, 2024 after the markets close.

January 23, 2024
·
2 min read
FDA

FDA Roundup: January 23, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

January 23, 2024
·
4 min read
Business

Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2023 financial results and provide 2024 guidance on Wednesday, February 14th, before the market opens.

January 23, 2024
·
1 min read